Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)

Healthcare >> CEO Interviews >> November 12, 2023

Dr. Frank Bedu-Addo has served as a director, president and CEO of PDS Biotechnology Corporation since its inception in 2005. Dr. Bedu-Addo is a veteran biotech executive with experience successfully starting and growing biotechnology organizations. He has been responsible for the development and implementation of both operational and drug development strategies, supervising and managing both large organizations and emerging biotechnology companies. Dr. Bedu-Addo was a founding and senior executive at KBI BioPharma, Inc. As Vice President of Drug Development, he oversaw all business and drug development operations. Before KBI, he successfully started and managed Cardinal Health’s East Coast biotechnology drug development operations. Prior, Dr. Bedu-Addo was an Associate Director at Akzo-Nobel, Senior Scientist at Elan (The Liposome Co.), and Principal Scientist at Schering-Plough. In these positions, he contributed to the development of numerous drugs, including antiviral and anticancer products. Dr. Bedu-Addo obtained his M.S. degree in chemical engineering and a Ph.D. in pharmaceutics from the University of Pittsburgh. Profile

Word count: 4,408

TWST: Maybe we could start out with a history of the company and an overview?

Dr. Bedu-Addo: Sure. So, PDS Biotechnology is a mid to late

Join for free to read a longer excerpt or purchase this article

Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS